4//SEC Filing
Floyd Robert Michael 4
Accession 0001567619-21-018171
CIK 0001533743other
Filed
Oct 7, 8:00 PM ET
Accepted
Oct 8, 4:34 PM ET
Size
7.0 KB
Accession
0001567619-21-018171
Insider Transaction Report
Form 4
Floyd Robert Michael
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2021-10-06−4,663→ 9,387 total - Exercise/Conversion
Common Stock
2021-10-06+12,500→ 14,500 total
Holdings
- 117,409(indirect: by Elion Oncology, Inc.)
Common Stock
Footnotes (1)
- [F1]Vesting of restricted stock.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001828217
Filing Metadata
- Form type
- 4
- Filed
- Oct 7, 8:00 PM ET
- Accepted
- Oct 8, 4:34 PM ET
- Size
- 7.0 KB